EMFAT
COLL icon

Emerald Mutual Fund Advisers Trust’s Collegium Pharmaceutical COLL Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-306,074
Closed -$10.1M – 203
2026
Q1 		$10.1M Sell
306,074
-85,596
-22% -$3.62M 0.49% 81
2025
Q4 		$18.1M Sell
391,670
-3,991
-1% -$167K 0.88% 44
2025
Q3 		$13.8M Sell
395,661
-154,973
-28% -$5.39M 0.71% 55
2025
Q2 		$16.3M Sell
550,634
-23,446
-4% -$669K 0.99% 34
2025
Q1 		$17.1M Buy
574,080
+4,513
+0.8% +$138K 1.22% 29
2024
Q4 		$16.3M Sell
569,567
-92,724
-14% -$3.07M 0.99% 40
2024
Q3 		$25.6M Buy
662,291
+131,835
+25% +$4.7M 1.33% 21
2024
Q2 		$17.1M Buy
530,456
+19,255
+4% +$668K 0.89% 45
2024
Q1 		$19.8M Sell
511,201
-40,593
-7% -$1.42M 1.03% 36
2023
Q4 		$17M Sell
551,794
-7,686
-1% -$193K 0.9% 42
2023
Q3 		$12.5M Sell
559,480
-117,680
-17% -$2.68M 0.75% 58
2023
Q2 		$14.6M Hold
677,160
– – 0.79% 62
2023
Q1 		$16.2M Sell
677,160
-8,733
-1% -$232K 0.96% 38
2022
Q4 		$15.9M Sell
685,893
-9,500
-1% -$192K 0.99% 42
2022
Q3 		$11.1M Sell
695,393
-12,446
-2% -$219K 0.7% 59
2022
Q2 		$12.5M Buy
707,839
+39,160
+6% +$659K 0.73% 57
2022
Q1 		$13.6M Buy
668,679
+18,281
+3% +$345K 0.6% 65
2021
Q4 		$12.1M Sell
650,398
-60,000
-8% -$1.17M 0.43% 81
2021
Q3 		$14M Sell
710,398
-79,993
-10% -$1.73M 0.49% 74
2021
Q2 		$18.7M Hold
790,391
– – 0.61% 68
2021
Q1 		$18.7M Buy
790,391
+2,362
+0.3% +$56.1K 0.62% 75
2020
Q4 		$15.8M Buy
788,029
+140,700
+22% +$2.75M 0.55% 79
2020
Q3 		$13.5M Buy
647,329
+123,066
+23% +$2.22M 0.6% 67
2020
Q2 		$9.18M Sell
524,263
-147,032
-22% -$2.88M 0.43% 80
2020
Q1 		$11M Sell
671,295
-93,617
-12% -$1.93M 0.69% 53
2019
Q4 		$15.7M Buy
+764,912
New +$12.7M 0.64% 54

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's COLL Position: Q2 2026 in Review

Emerald Mutual Fund Advisers Trust sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 306,074 shares — an estimated $10.1M sold.

Emerald Mutual Fund Advisers Trust first reported a position in COLL in Q4 2019 and held it in 26 quarters. The position peaked at $25.6M in Q3 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Emerald Mutual Fund Advisers Trust reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 306,074 Collegium Pharmaceutical shares in Q2 2026, an estimated $10.1M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Collegium Pharmaceutical in Q4 2019 and held it in 26 quarters.
  • Emerald Mutual Fund Advisers Trust's Collegium Pharmaceutical position peaked at $25.6M in Q3 2024.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2026, filed 5 Aug 2026.